Prof. Ananchai discusses “marijuana research”, moving forward, aiming to treat cancer in 3 areas, “reducing disease progression”, pointing out that the problem is urgent to solve, doctors do not dare to prescribe The reason is that there is still less information used, but foreign research has surpassed it. market drug production
On February 6, at the Ministry of Public Health (Sor Sor.) Dr. Ananchai Assawamakhin Chair of the Subcommittee on Education/Research on Medical and Health Cannabis Use said later as the chairman of the meeting of the Sub-Committee in collaboration with relevant agencies both inside and outside the Ministry of Public Health On research issues related to medical marijuana that since the marijuana was allowed for medical use in 2019 until now There is research that has been completed. There are 64 issues in total and 42 are in progress. A number of completed researches have been put to good use, such as supporting the incorporation of cannabis into the National List of Essential Medicines. and registration of herbal products In which the work plan of the subcommittee in 2023 is to use research results for the benefit of policy formulation. Contents in the benefit pack product registration and determining the direction of cannabis research to answer the country’s health problems by integrating collaboration with various agencies both domestically and internationally
Dr. Ananchai said that today the Sub-Committee It can be concluded that there are 4 issues that we must operate together as follows: 1. Integration workin conjunction with the committee to supervise the direction of research on marijuana critical issues of the country, appointed by the Office of the Science Promotion Commission Research and Innovation (TSRI) to achieve unified work and maximum efficiency. The director of the Health Systems Research Institute will discuss the matter with the steering committee. to find ways to work together 2.Collect research datathat have already been carried out and are in progress to answer social questions about the impact on society economy and health which from considering the information today About half of the studies were conducted to study the effects. which should be urgently taken into account for discussion and exchange and find preliminary conclusions to answer preliminary questions of society including research gap analysis in order to carry out the fulfillment to answer the questions of the society In the next meeting, relevant agencies that have studied this matter will be invited to discuss and exchange. to find a preliminary conclusion and will inform the society
Dr. Ananchai said that 3. Determine the country’s cannabis research direction. Today, the Institute of Medical Cannabis presented research directions for cannabis medicine in cancer. Because this disease is the leading cause of death for Thai people. Although marijuana is included in the national list of essential medicines for indications for relieving symptoms in patients with advanced cancer. But doctors still prescribe less. because there is still a lack of high standard academic evidence In foreign countries, there is more research on this subject. By developing drug formulas to be specific and researching in 3 areas: reducing side effects from chemotherapy drugs Alleviate symptoms and control the progression of the disease. Thailand should take this seriously. because now almost all cancer drugs we have to import 4.Bringing research to support commercial use Today, the Food and Drug Administration (FDA) has come to present preliminary product registration guidelines. In the ministry, there are many agencies that research and develop drugs. which the sub-committee will invite to a sub-group meeting to discuss so that research products can be registered immediately after the research is completed
“To drive these 4 issues, we will integrate with other units. To achieve maximum utilization of resources and time. that must be done quickly because now many countries are allowing marijuana to use as well We must take the opportunity as the first country in Asia to have a policy to drive cannabis for health and the economy,” Dr. Ananchai said.
